Skip to content

Stitch Closure of PFO and Septal Repair

Suture Mediated Septal Defect Closure/Repair Evaluation of the NobleStitch EL System

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03373929
Acronym
STITCH
Enrollment
250
Registered
2017-12-14
Start date
2017-11-20
Completion date
2022-11-20
Last updated
2017-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foramen Ovale, Patent, Septal Defect, Atrial, Septal Defect, Heart

Brief summary

The purpose of the STITCH study is to evaluate closure rates of clinically relevant septal defects, including patent foramen ovale (PFO), Atrial Septal Defects (ASD - less than 1 cm with redundant septal tissue), trans septal puncture sites, repair of Atrial Septal Aneurysm (ASA) and rate of recurrent neurologic embolic events in patients with cryptogenic stroke and PFO.

Interventions

DEVICEPFO Closure Rate

Suture Mediated PFO Closure and Septal Repair

DEVICEPublished PFO Device Closure

Suture Mediated PFO Closure and Septal Repair

Sponsors

HeartStitch.Com
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Non-randomized, single-center, observational study

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* PFO * ASD (less than 1 cm with redundant septal tissue) * Trans Septal Puncture Sites * ASA (when an appropriate PFO or small ASD defect is present) * Stroke * Trans ischemic Attack (TIA) * Platypnea Orthodeoxia Syndrome * Decompression Illness

Exclusion criteria

* Patients under 18 and over 65 * Patients who are not fluent in English

Design outcomes

Primary

MeasureTime frameDescription
Closure Rates of PFO and ASD12 monthsSaline Contrast Echo

Secondary

MeasureTime frameDescription
Recurrent Stroke Rate4-6 weeks, 6 months, 1 year and annually up to five yearsRate of which Patient Experiences Recurrent Stroke

Other

MeasureTime frameDescription
Migraine4-6 weeks, 6 months, 1 year and annually up to five yearsRate of Patients who have Experienced Improvement in Migraine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026